24.3 C
London
Friday, June 9, 2023
HomeHealthThe first testosterone patch was developed to combat menopause

The first testosterone patch was developed to combat menopause

Date:

The first testosterone patch was developed to combat menopause and the inventors say it may increase libido in women

British researchers have developed the world’s first testosterone patch for women with postmenopausal symptoms.

Medherant aims to begin clinical trials in the fall. If the treatment wins regulatory approval, it will be the only testosterone replacement patch available globally and will be offered first in the UK.

David Hadlton, founder of Medherant, a professor at the University of Warwick, said the potential to improve women’s lives by helping them lose their sex drive was “huge”.

Women seeking treatment for the effects of menopause on libido cannot currently be prescribed testosterone on the NHS.

Experts say some resort to irregular doses of the gel that is only approved for use on men.

Medherant aims to begin clinical trials in the fall. If the treatment wins regulatory approval, it will be the only testosterone replacement patch available globally and will be offered first in the UK (file photo)

Testosterone is an essential hormone for women and its production decreases dramatically after menopause.

Although estrogen-progesterone replacement therapy (HRT) patches — which stick to the skin to deliver drugs — are available, there is no testosterone delivery patch for women with negative menopausal symptoms.

Professor Huddleton said: “This is a very exciting development for us – the potential for this technology to improve women’s lives is huge.

The work we do at Medherant and Warwick is not merely theoretical, but instead aims at a problem women face that can significantly affect their daily lives and jobs.

This can lead to a much needed product that is out of stock.

With technology already proven to work, we can use our new patch to remove needless misery from women’s everyday lives.

“We hope that this will transform the lives of women with postmenopausal issues nationally and indeed globally.”

Since 2015, guidelines from the National Institute for Health and Care Excellence have recommended that testosterone supplementation be considered for postmenopausal women with reduced libido if HRT has not been effective.

The new patch aims to address this gap in menopause products, providing a specific treatment for women that could be made widely available.

Last summer, the Daily Mail’s HRT campaign scored a huge victory after pharmacists were allowed to prescribe alternatives to out-of-stock HRT treatments.

(tags to translate) Daily Mail

Merryhttps://whatsnew2day.com/
Merry C. Vega is a highly respected and accomplished news author. She began her career as a journalist, covering local news for a small-town newspaper. She quickly gained a reputation for her thorough reporting and ability to uncover the truth.

Latest stories

spot_img